Basilea Pharmaceutica (BPMUF) News Today $67.75 0.00 (0.00%) As of 08/28/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock BPMUF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Basilea Pharmaceutica's (VTX:BSLN) Earnings Are Weaker Than They SeemAugust 27 at 11:54 PM | finance.yahoo.comBasilea Pharmaceutica AG (BPMUF) Q2 2025 Earnings Conference Call TranscriptAugust 19, 2025 | seekingalpha.comBasilea on track with strong 2025 half-year resultsAugust 19, 2025 | globenewswire.comBasilea Pharmaceutica AG (OTCMKTS:BPMUF) Sees Large Drop in Short InterestAugust 16, 2025 | marketbeat.comBasilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest UpdateAugust 3, 2025 | marketbeat.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Reaches New 52-Week High - Time to Buy?July 31, 2025 | marketbeat.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Trading Up 10.4% - Should You Buy?July 31, 2025 | marketbeat.comBasilea Pharmaceutica AG (BPMUF) - Yahoo FinanceJuly 11, 2025 | nz.finance.yahoo.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Reaches New 12-Month High - Still a Buy?July 1, 2025 | marketbeat.comShort Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Declines By 97.6%June 11, 2025 | marketbeat.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Stock Price Up 13.1% - Still a Buy?June 6, 2025 | marketbeat.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Sets New 1-Year High - Time to Buy?June 6, 2025 | marketbeat.comBasilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Up 4,000.0% in MayMay 30, 2025 | marketbeat.comIs Basilea Pharmaceutica AG (VTX:BSLN) Expensive For A Reason? A Look At Its Intrinsic ValueMay 19, 2025 | finance.yahoo.comAssessment of the 14-Alpha Demethylase Inhibitors Pipeline Landscape 2025, Featuring Insights Into Oteseconazole (Mycovia Pharmaceuticals) and Isavuconazonium (Basilea Pharmaceutica)May 8, 2025 | globenewswire.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Hits New 52-Week Low - Here's WhyApril 24, 2025 | marketbeat.comStrong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to BasileaApril 24, 2025 | finance.yahoo.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Reaches New 52-Week Low - Here's WhyApril 16, 2025 | marketbeat.comBasilea Pharmaceutica AG (OTCMKTS:BPMUF) Sees Significant Drop in Short InterestApril 16, 2025 | marketbeat.comBasilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025April 16, 2025 | uk.finance.yahoo.comBasilea Pharmaceutica (VTX:BSLN investor five-year losses grow to 16% as the stock sheds CHF67m this past weekApril 8, 2025 | uk.finance.yahoo.comAnalysts Set Expectations for OTCMKTS:BPMUF FY2025 EarningsMarch 31, 2025 | marketbeat.comShort Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Declines By 86.6%March 27, 2025 | marketbeat.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Sets New 12-Month High - Here's What HappenedMarch 25, 2025 | marketbeat.comBasilea Pharmaceutica's (VTX:BSLN) Promising Earnings May Rest On Soft FoundationsFebruary 26, 2025 | uk.finance.yahoo.comFull Year 2024 Basilea Pharmaceutica AG Allschwil Earnings Call TranscriptFebruary 19, 2025 | gurufocus.comBasilea projects CHF220M in 2025 revenue with key pipeline advancements and U.S. launch of ZevteraFebruary 18, 2025 | msn.comShort Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Expands By 34.8%February 15, 2025 | marketbeat.comKepler Capital Remains a Buy on Basilea Pharmaceutica (BSLN)February 9, 2025 | markets.businessinsider.comStrong launch for Cresemba in Japan triggers first sales milestone payment from AKP to BasileaFebruary 5, 2025 | finance.yahoo.comStrong sales growth for Cresemba and Zevtera trigger further milestone payments to BasileaJanuary 28, 2025 | uk.finance.yahoo.comShort Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Drops By 34.4%January 15, 2025 | marketbeat.comBasilea provides portfolio update and outlookJanuary 8, 2025 | finance.yahoo.comKepler Capital Sticks to Their Buy Rating for Basilea Pharmaceutica (BSLN)December 21, 2024 | markets.businessinsider.comKepler Capital Keeps Their Buy Rating on Basilea Pharmaceutica (BSLN)December 18, 2024 | markets.businessinsider.comInnoviva enters distribution, license agreement with Basilea for ZevteraDecember 17, 2024 | markets.businessinsider.comBasilea Pharmaceutica AG (BSLN.SW)November 10, 2024 | finance.yahoo.comBasilea Pharmaceutica (OTCMKTS:BPMUF) Hits New 12-Month High - What's Next?October 24, 2024 | marketbeat.comStrong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this region to Basilea this yearOctober 10, 2024 | markets.businessinsider.comBasilea initiates clinical phase 3 study with antifungal fosmanogepix in candidemia and invasive candidiasisSeptember 24, 2024 | markets.businessinsider.comBasilea Pharmaceutica (BSLN) Gets a Buy from Kepler CapitalSeptember 22, 2024 | markets.businessinsider.comBasilea Reaches Deal With BARDA To Develop Novel Antifungals And Antibacterials; Raises FY OutlookSeptember 19, 2024 | markets.businessinsider.comStrong Cresemba® (isavuconazole) sales performance in Europe triggers USD 25 million sales milestone payment to BasileaSeptember 6, 2024 | markets.businessinsider.comBasilea Receives $25 Mln Milestone Payment Following Strong Cresemba Sales Performance In EuropeSeptember 6, 2024 | markets.businessinsider.comHC Wainwright Weighs in on Basilea Pharmaceutica AG's FY2024 Earnings (OTCMKTS:BPMUF)August 30, 2024 | marketbeat.comBasilea Pharmaceutica AG (BPMUF)August 29, 2024 | finance.yahoo.comShort Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Declines By 57.0%August 28, 2024 | marketbeat.comHalf Year 2024 Basilea Pharmaceutica AG Allschwil Earnings Call TranscriptAugust 16, 2024 | gurufocus.comBasilea reports strong 2024 half-year results and significantly increases full-year revenue and profit guidanceAugust 13, 2024 | markets.businessinsider.comBasilea Pharma H1 Results Down; Lifts FY24 GuidanceAugust 13, 2024 | markets.businessinsider.com Get Basilea Pharmaceutica News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMUF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BPMUF Media Mentions By Week BPMUF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMUF News Sentiment▼-0.881.03▲Average Medical News Sentiment BPMUF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMUF Articles This Week▼10▲BPMUF Articles Average Week Get the Latest News and Ratings for BPMUF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Basilea Pharmaceutica and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies APLS News Today MENS News Today MTSR News Today SRRK News Today KYMR News Today AMRX News Today XENE News Today ARWR News Today VKTX News Today CRNX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BPMUF) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basilea Pharmaceutica AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Basilea Pharmaceutica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access